Oral contraceptive use for the primary prevention of ovarian cancer.
Havrilesky LJ, Gierisch JM, Moorman PG, Coeytaux RR, Urrutia RP, Lowery WJ, Dinan M, McBroom AJ, Wing L, Musty MD, Lallinger KR, Hasselblad V, Sanders GD, Myers ER.
Havrilesky LJ, et al. Among authors: sanders gd.
Evid Rep Technol Assess (Full Rep). 2013 Jun;(212):1-514.
Evid Rep Technol Assess (Full Rep). 2013.
PMID: 24423062
Free PMC article.
Review.